KLAS Contact
Contact KLAS
Contact KLAS
2022 BEST IN KLAS
Preferences
Related Series
2022
2020
2018
2017
2015
2013
2012
2011
2011
2010
2009
2008
2008
2008
2007
2006
2006
2006
2005
2005
2005
Related Segments
Community Hospital PACS 2007
Current Time Inside Cache Tag Helper: 12/2/2022 9:41:45 AM and Model.reportId = 467
As the PACS market continues to grow, more and more community care delivery organizations find it difficult to stay competitive without a PACS solution. With so many options available, deciding which solution to choose may be trickier than ever. Frequently, providers and vendors alike find themselves wondering what drives PACS purchasing decisions.KLAS’ most recent Community Hospital PACS report offers insights shared by providers across the country into today’s PACS market, market trends and findings and performance reports on vendors in the market space. Additionally, this study provides a snapshot of today’s community hospital PACS vendor products and compares their strengths and weaknesses against one another, all community hospital PACS vendors and the KLAS HIT average (the average of all healthcare information technology products in the KLAS database).
Partially due to the large number of vendors in this market, PACS contains more KLAS rated vendors than almost any other segment. Vendors included in this report are:
- Agfa
- AMICAS
- Aspyra
- BRIT Systems
- DR Systems
- Dynamic Imaging
- FUJIFILM
- GE
- Infinitt
- McKesson
- Merge Healthcare
- NovaRad
- Philips
- Sectra
Early data is included in the report for Avreo, Carestream (Kodak), Cerner, Emageon, eRAD, Intelerad, OpenMed, Ramsoft, ScImage and Siemens.
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2022 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.